Lentivirus
Links shared publicly online about this topic
Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced ... http://bit.ly/aBWKvS
nature.com — “Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced ... http://bit.ly/aBWKvS” View full resource at nature.com
Most Recently Shared on June 3, 2010 at 5:29 pm By:
Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced ... http://bit.ly/aBWKvS
Gene Therapy For Metastatic Melanoma In Mice Produces Complete Remission, Indiana University Cancer Researchers Report
medicalnewstoday.com — “A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article t” View full resource at medicalnewstoday.com
Most Recently Shared on November 19, 2010 at 5:05 pm By:
Gene Therapy For Metastatic Melanoma In Mice Produces Complete Remission, Indiana University Cancer Researchers Report http://mnt.to/3MRZ
RNAi, smuggled in a virus, weakens tumors before final radiation blow - FierceBiotech Research
fiercebiotechresearch.com — “RNAi may be a great way to help weaken cancer cells before radiation therapy delivers the killing blow. Emory University scientists used modified lentiviruses to conceal RNA molecules and sneak them Read more...” View full resource at fiercebiotechresearch.com
Most Recently Shared on March 19, 2012 at 1:15 pm By:
RNAi, smuggled in a virus, weakens tumors before final radiation blow http://t.co/LAUicyYt #cancer
NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles
news-medical.net — “Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).” View full resource at news-medical.net
Most Recently Shared on December 9, 2009 at 5:42 pm By:
NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles: Lentigen Corporation, a ... http://bit.ly/7wv1G6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
OrganizedWisdom RA
Organizing rheumatoid arthritis resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Genetics News
The latest genetics news published daily. Articles from research centers, universities and prestigious journals.
-
FierceBiotech
FierceBiotech's 140, written by Managing Editor Maureen Martino. Join the largest and most active biotech news readership in the world at FierceBiotech.com.
Advertisement
